EVANSVILLE, Ind.--(BUSINESS WIRE)--Results of a new study released this week in the June 2010 issue of The Journal of Pediatrics show that infants fed Enfamil® LIPIL® containing DHA and ARA during the first year of life experienced improved immune outcomes, including improved respiratory health, versus infants fed the same formulation without these beneficial lipids – and this health benefit was shown for the first three years of life. The study was conducted by researchers at the Retina Foundation of the Southwest.
